Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity
Authors:
Open Access
- 1 March 2009
- journal article
- research article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 41 (3) , 223-230
Abstract
Survivin, a member of inhibitor of apoptosis family protein, has become an attractive therapeutic target in cancer due to its selective expression in tumor cells and its important roles for tumor cell viability. Here, we show that vector-based small interfering RNAs (siRNAs) silenced survivin expression in prostate cancer cells, resulting in significantly reduced cell proliferation and enhanced apoptosis, and increased the sensitivity of prostate cancer cells (PC-3) to the apoptosis-inducing agent, platinol. Furthermore, PC-3 cells transfected with the siRNA-expressing vector showed lower tumor formation in nude mice xenografts in vivo. These results demonstrated that inhibition of survivin expression by siRNA attenuated the malignant phenotypes of prostate cancer cells, and may provide a novel approach for gene therapy of androgen-independent prostate cancer.Keywords
This publication has 26 references indexed in Scilit:
- CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulationJournal of Biological Chemistry, 2008
- Detection of Newly Diagnosed Bladder Cancer, Bladder Cancer Recurrence and Bladder Cancer in Patients with Hematuria Using Quantitative RT-PCR of Urinary SurvivinTumor Biology, 2007
- Survivin as a target for new anticancer interventionsJournal of Cellular and Molecular Medicine, 2005
- Survivin mediates resistance to antiandrogen therapy in prostate cancerOncogene, 2005
- Adenovirus-Mediated Transfer of siRNA against Survivin Induced Apoptosis and Attenuated Tumor Cell Growth in Vitro and in VivoMolecular Therapy, 2004
- Expression of the Survivin Gene in Prostate Cancer: Correlation With Clinicopathological Characteristics, Proliferative Activity and ApoptosisJournal of Urology, 2004
- Survivin expression is associated with features of biologically aggressive prostate carcinomaCancer, 2004
- Survivin, versatile modulation of cell division and apoptosis in cancerOncogene, 2003
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003
- Inhibitors of apoptosis proteins in prostate cancer cell linesThe Prostate, 2002